{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T11:41:52Z","timestamp":1790336512578,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Bioprojet Pharma"},{"name":"Harmony Biosciences, LLC, Plymouth Meeting, PA, USA"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sleep Medicine"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.sleep.2019.10.024","type":"journal-article","created":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T11:49:50Z","timestamp":1575460190000},"page":"220-226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Pharmacokinetics of pitolisant in children and adolescents with narcolepsy"],"prefix":"10.1016","volume":"66","author":[{"given":"Michel","family":"Lecendreux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1051-0472","authenticated-orcid":false,"given":"Giuseppe","family":"Plazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyne","family":"Jacqz-Aigrain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Robert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Duvauchelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Charles","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.sleep.2019.10.024_bib1","series-title":"The international classification of sleep disorders","year":"2014"},{"key":"10.1016\/j.sleep.2019.10.024_bib2","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1056\/NEJMra1500587","volume":"373","author":"Scammell","year":"2015","journal-title":"Narcolepsy. N Engl J Med"},{"key":"10.1016\/j.sleep.2019.10.024_bib3","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jpsychores.2005.06.065","article-title":"How age influences the expression of narcolepsy","volume":"59","author":"Ohayon","year":"2005","journal-title":"J\u00a0Psychosom Res"},{"key":"10.1016\/j.sleep.2019.10.024_bib4","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/jsr.12044","article-title":"Clinical, polysomnographic and genome-wide association analyses of narcolepsy with cataplexy: a European Narcolepsy Network study","volume":"22","author":"Luca","year":"2013","journal-title":"J\u00a0Sleep Res"},{"key":"10.1016\/j.sleep.2019.10.024_bib5","doi-asserted-by":"crossref","first-page":"419","DOI":"10.5664\/jcsm.6494","article-title":"Listening to the patient voice in narcolepsy: diagnostic delay, disease burden, and treatment efficacy","volume":"13","author":"Maski","year":"2017","journal-title":"J\u00a0Clin Sleep Med"},{"key":"10.1016\/j.sleep.2019.10.024_bib6","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1093\/sleep\/33.11.1457","article-title":"Clinical and therapeutic aspects of childhood narcolepsy-cataplexy: a retrospective study of 51 children","volume":"33","author":"Aran","year":"2010","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2019.10.024_bib7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.pediatrneurol.2018.06.008","article-title":"Clinical characteristics and burden of illness in pediatric patients with narcolepsy","volume":"85","author":"Plazzi","year":"2018","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.sleep.2019.10.024_bib8","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.smrv.2017.04.003","article-title":"The clinical spectrum of childhood narcolepsy","volume":"38","author":"Postiglione","year":"2018","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.sleep.2019.10.024_bib9","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s11910-014-0469-1","article-title":"The diagnosis and treatment of pediatric narcolepsy","volume":"14","author":"Nevsimalova","year":"2014","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.sleep.2019.10.024_bib10","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/mds.21965","article-title":"Cataplexy features in childhood narcolepsy","volume":"23","author":"Serra","year":"2008","journal-title":"Mov Disord"},{"key":"10.1016\/j.sleep.2019.10.024_bib11","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1093\/brain\/awr244","article-title":"Complex movement disorders at disease onset in childhood narcolepsy with cataplexy","volume":"134","author":"Plazzi","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.sleep.2019.10.024_bib12","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11940-017-0459-0","article-title":"Cataplexy and its mimics: clinical recognition and management","volume":"19","author":"Pillen","year":"2017","journal-title":"Curr Treat Options Neurol"},{"key":"10.1016\/j.sleep.2019.10.024_bib13","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.sleep.2003.10.006","article-title":"A\u00a0putative link between childhood narcolepsy and obesity","volume":"5","author":"Kotagal","year":"2004","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2019.10.024_bib14","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/cns.12105","article-title":"Impact of obesity in children with narcolepsy","volume":"19","author":"Odilla Inocente","year":"2013","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.sleep.2019.10.024_bib15","doi-asserted-by":"crossref","first-page":"175","DOI":"10.5665\/sleep.2366","article-title":"High prevalence of precocious puberty and obesity in childhood narcolepsy with cataplexy","volume":"36","author":"Poli","year":"2013","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2019.10.024_bib16","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/cns.12291","article-title":"Quality of life in children with narcolepsy","volume":"20","author":"Inocente","year":"2014","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.sleep.2019.10.024_bib17","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.5664\/jcsm.6352","article-title":"Growing up with type 1 narcolepsy: its anthropometric and endocrine features","volume":"12","author":"Ponziani","year":"2016","journal-title":"J\u00a0Clin Sleep Med"},{"key":"10.1016\/j.sleep.2019.10.024_bib18","series-title":"Ritalin\u00ae (methylphenidate hydrochloride) USP tablets CII [package insert]","year":"2013"},{"key":"10.1016\/j.sleep.2019.10.024_bib19","series-title":"Adderall\u00ae (dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets) CII [package insert]","year":"2017"},{"key":"10.1016\/j.sleep.2019.10.024_bib20","series-title":"Dexedrine\u00ae (dextroamphetamine sulfate) spansule\u00ae sustained-release capsules CII [package insert]","year":"2017"},{"key":"10.1016\/j.sleep.2019.10.024_bib21","series-title":"Xyrem\u00ae (sodium oxybate) oral solution CIII [package insert]","year":"2018"},{"key":"10.1016\/j.sleep.2019.10.024_bib22","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S2352-4642(18)30133-0","article-title":"Treatment of paediatric narcolepsy with sodium oxybate: a double-blind, placebo-controlled, randomised-withdrawal multicentre study and open-label investigation","volume":"2","author":"Plazzi","year":"2018","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.sleep.2019.10.024_bib23","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s40272-014-0083-3","article-title":"Pharmacological management of narcolepsy and cataplexy in pediatric patients","volume":"16","author":"Lecendreux","year":"2014","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.sleep.2019.10.024_bib24","series-title":"Wakix\u00ae (pitolisant) tablets, for oral use [package insert]","year":"2019"},{"key":"10.1016\/j.sleep.2019.10.024_bib25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.sleep.2014.10.002","article-title":"Clinical and practical considerations in the pharmacologic management of narcolepsy","volume":"16","author":"Thorpy","year":"2015","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2019.10.024_bib26","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1476-5381.2011.01286.x","article-title":"The histamine H3 receptor: from discovery to clinical trials with pitolisant","volume":"163","author":"Schwartz","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.sleep.2019.10.024_bib27","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.sleep.2017.01.002","article-title":"The European medicines agency review of pitolisant for treatment of narcolepsy: summary of the scientific assessment by the committee for medicinal products for human use","volume":"33","author":"Kollb-Sielecka","year":"2017","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2019.10.024_bib28","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1124\/jpet.106.111039","article-title":"BF2.649 [1-{3-[3-(4-Chlorophenyl)propoxy]propyl}piperidine, hydrochloride], a nonimidazole inverse agonist\/antagonist at the human histamine H3 receptor: preclinical pharmacology","volume":"320","author":"Ligneau","year":"2007","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.sleep.2019.10.024_bib29","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1124\/jpet.110.170134","article-title":"Histamine H3 receptors and sleep-wake regulation","volume":"336","author":"Lin","year":"2011","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.sleep.2019.10.024_bib30","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/cns.13057","article-title":"Impaired histaminergic neurotransmission in children with narcolepsy type 1","volume":"25","author":"Franco","year":"2019","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.sleep.2019.10.024_bib31","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S1474-4422(13)70225-4","article-title":"Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial","volume":"12","author":"Dauvilliers","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.sleep.2019.10.024_bib32","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S1474-4422(16)30333-7","article-title":"Safety and efficacy of pitolisant on cataplexy in patients with narcolepsy: a randomised, double-blind, placebo-controlled trial","volume":"16","author":"Szakacs","year":"2017","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.sleep.2019.10.024_bib33","series-title":"Wakix summary of product characteristics [SPC]","year":"2019"},{"key":"10.1016\/j.sleep.2019.10.024_bib34","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s40265-016-0620-1","article-title":"Pitolisant: first global approval","volume":"76","author":"Syed","year":"2016","journal-title":"Drugs"},{"key":"10.1016\/j.sleep.2019.10.024_bib35","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3390\/pharmaceutics3010053","article-title":"Factors and mechanisms for pharmacokinetic differences between pediatric population and adults","volume":"3","author":"Fernandez","year":"2011","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.sleep.2019.10.024_bib36","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4155\/ipk-2016-0001","article-title":"Pharmacokinetic considerations when prescribing in children","volume":"1","author":"Eidelman","year":"2016","journal-title":"Intern J Pharmacokinet"}],"container-title":["Sleep Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945719316314?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945719316314?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T15:19:22Z","timestamp":1761405562000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1389945719316314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":36,"alternative-id":["S1389945719316314"],"URL":"https:\/\/doi.org\/10.1016\/j.sleep.2019.10.024","relation":{},"ISSN":["1389-9457"],"issn-type":[{"value":"1389-9457","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacokinetics of pitolisant in children and adolescents with narcolepsy","name":"articletitle","label":"Article Title"},{"value":"Sleep Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sleep.2019.10.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}